With successful trials, Roche takes its MS drug to regulators, but safety questions loom - statnews.com
With successful trials, Roche takes its MS drug to regulators, but safety questions loom statnews.com
With successful trials, Roche takes its MS drug to regulators, but safety questions loom statnews.com
A compact weekly email covering company moves, product signals, regulatory updates, and notable funding.